These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 23175624)

  • 1. ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).
    Ghielmini M; Vitolo U; Kimby E; Montoto S; Walewski J; Pfreundschuh M; Federico M; Hoskin P; McNamara C; Caligaris-Cappio F; Stilgenbauer S; Marcus R; Trneny M; Dreger P; Montserrat E; Dreyling M;
    Ann Oncol; 2013 Mar; 24(3):561-76. PubMed ID: 23175624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma.
    Dreyling M; Thieblemont C; Gallamini A; Arcaini L; Campo E; Hermine O; Kluin-Nelemans JC; Ladetto M; Le Gouill S; Iannitto E; Pileri S; Rodriguez J; Schmitz N; Wotherspoon A; Zinzani P; Zucca E
    Ann Oncol; 2013 Apr; 24(4):857-77. PubMed ID: 23425945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma.
    Buske C; Hutchings M; Ladetto M; Goede V; Mey U; Soubeyran P; Spina M; Stauder R; Trněný M; Wedding U; Fields P;
    Ann Oncol; 2018 Mar; 29(3):544-562. PubMed ID: 29194473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan.
    Pei SN; Wang MC; Ma MC; Kuo CY; Liao CK; Qiu H; Rothwell LA; Liu Y
    Sci Rep; 2021 May; 11(1):10069. PubMed ID: 33980914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma.
    Falchi L; Ferrajoli A; Jacobs I; Nava-Parada P
    Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):508-518.e14. PubMed ID: 29934061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.
    Ladetto M; Buske C; Hutchings M; Dreyling M; Gaidano G; Le Gouill S; Luminari S; Pott C; Zamò A; Zucca E;
    Ann Oncol; 2016 Dec; 27(12):2149-2160. PubMed ID: 27701070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.
    Keating GM
    Drugs; 2010 Jul; 70(11):1445-76. PubMed ID: 20614951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial.
    Qin Y; Song Y; Shen Z; Du X; Ji W; Hsu W; Zhu J; Shi Y
    Cancer Commun (Lond); 2018 May; 38(1):31. PubMed ID: 29843792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Hagemeister F
    Drugs; 2010 Feb; 70(3):261-72. PubMed ID: 20166765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Richter syndrome with follicular colonization of chronic lymphocytic leukemia/small lymphocytic lymphoma cells mimicking follicular lymphoma.
    Tabata R; Tabata C; Nagai T; Yasumizu R; Kojima M
    Int J Surg Pathol; 2014 Dec; 22(8):736-43. PubMed ID: 24249845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
    Maeshima AM; Taniguchi H; Fukuhara S; Morikawa N; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
    Am J Surg Pathol; 2013 Apr; 37(4):563-70. PubMed ID: 23426122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphoma.
    Tomita N; Takasaki H; Fujisawa S; Miyashita K; Ogusa E; Kishimoto K; Matsuura S; Sakai R; Koharazawa H; Yamamoto W; Fujimaki K; Fujita H; Ishii Y; Taguchi J; Kuwabara H; Motomura S; Ishigatsubo Y
    J Clin Exp Hematop; 2013; 53(2):121-5. PubMed ID: 23995108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients.
    Hutchings M; Ladetto M; Buske C; de Nully Brown P; Ferreri AJM; Pfreundschuh M; Schmitz N; Balari AS; van Imhoff G; Walewski J;
    Ann Oncol; 2018 Aug; 29(8):1687-1700. PubMed ID: 29924296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
    Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
    Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network.
    Kane E; Painter D; Smith A; Crouch S; Oliver S; Patmore R; Roman E
    Cancer Epidemiol; 2019 Apr; 59():236-243. PubMed ID: 30844679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper.
    Cuneo A; Barosi G; Danesi R; Fagiuoli S; Ghia P; Marzano A; Montillo M; Poletti V; Viale P; Zinzani PL
    Hematol Oncol; 2019 Feb; 37(1):3-14. PubMed ID: 30187496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of obinutuzumab in Chinese patients with B-cell lymphomas.
    Zhai J; Qin Y; Zhu J; Song Y; Shen Z; Du X; Jamois C; Brewster M; Shi Y; Shi J
    Br J Clin Pharmacol; 2017 Jul; 83(7):1446-1456. PubMed ID: 28072473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.